Daily Journal Staff Writer
In the past, when a private investor threatened a hostile takeover, many companies defended themselves with a "poison pill," a defensive maneuever that devalues a company's stock by increasing the amount of shares for each shareholder except the potential buyer.
But recently - after nearly 30 years of popularity - the tack has been losing ground to other strategies.
Some corpora...
To continue reading, please subscribe.
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In